Seyfried CA - Search Results

1

Indolebutylamines as selective 5-HT(1A) agonists.

Heinrich T, Böttcher H, Bartoszyk GD, Greiner HE, Seyfried CA, Van Amsterdam C. Heinrich T, et al. Among authors: seyfried ca. J Med Chem. 2004 Sep 9;47(19):4677-83. doi: 10.1021/jm040792y. J Med Chem. 2004. PMID: 15341483

2

EMD 281014, a new selective serotonin 5-HT2A receptor antagonist.

Bartoszyk GD, van Amsterdam C, Böttcher H, Seyfried CA. Bartoszyk GD, et al. Among authors: seyfried ca. Eur J Pharmacol. 2003 Jul 25;473(2-3):229-30. doi: 10.1016/s0014-2999(03)01992-7. Eur J Pharmacol. 2003. PMID: 12892843

3

Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.

Heinrich T, Böttcher H, Schiemann K, Hölzemann G, Schwarz M, Bartoszyk GD, van Amsterdam C, Greiner HE, Seyfried CA. Heinrich T, et al. Among authors: seyfried ca. Bioorg Med Chem. 2004 Sep 15;12(18):4843-52. doi: 10.1016/j.bmc.2004.07.014. Bioorg Med Chem. 2004. PMID: 15336263

4

Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.

Heinrich T, Böttcher H, Gericke R, Bartoszyk GD, Anzali S, Seyfried CA, Greiner HE, Van Amsterdam C. Heinrich T, et al. Among authors: seyfried ca. J Med Chem. 2004 Sep 9;47(19):4684-92. doi: 10.1021/jm040793q. J Med Chem. 2004. PMID: 15341484

5

SAR of novel biarylmethylamine dopamine D4 receptor ligands.

Arlt M, Böttcher H, Riethmüller A, Schneider G, Bartoszyk GD, Greiner H, Seyfried CA. Arlt M, et al. Among authors: seyfried ca. Bioorg Med Chem Lett. 1998 Aug 4;8(15):2033-8. doi: 10.1016/s0960-894x(98)00361-8. Bioorg Med Chem Lett. 1998. PMID: 9873481

6

5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.

Matzen L, van Amsterdam C, Rautenberg W, Greiner HE, Harting J, Seyfried CA, Böttcher H. Matzen L, et al. Among authors: seyfried ca. J Med Chem. 2000 Mar 23;43(6):1149-57. doi: 10.1021/jm9811054. J Med Chem. 2000. PMID: 10737747

7

Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.

van Amsterdam C, Seyfried CA. van Amsterdam C, et al. Among authors: seyfried ca. Psychopharmacology (Berl). 2014 Jun;231(12):2547-58. doi: 10.1007/s00213-013-3428-7. Epub 2014 Jan 14. Psychopharmacology (Berl). 2014. PMID: 24419272

8

Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.

Haase AF, Greiner HE, Seyfried CA. Haase AF, et al. Among authors: seyfried ca. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jun;343(6):588-94. doi: 10.1007/BF00184289. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1682817

9

Biochemical and functional studies on EMD 49,980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems.

Seyfried CA, Greiner HE, Haase AF. Seyfried CA, et al. Eur J Pharmacol. 1989 Jan 24;160(1):31-41. doi: 10.1016/0014-2999(89)90651-1. Eur J Pharmacol. 1989. PMID: 2565817

10

Sensitivity of dopamine D2 receptors following long-term treatment with roxindole.

Seyfried CA, Bartoszyk GD. Seyfried CA, et al. Eur J Pharmacol. 1994 May 12;257(1-2):67-72. doi: 10.1016/0014-2999(94)90695-5. Eur J Pharmacol. 1994. PMID: 7915991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters